Rapid clinical mutational testing of <i>KRAS</i>, <i>BRAF</i> and <i>EGFR</i>: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing

Abstract

Our observations demonstrate that the Idylla cartridge for the <i>EGFR</i>, <i>KRAS</i> and <i>BRAF</i> mutations is highly accurate, rapid and has a limited hands-on time compared with next-generation sequencing.